Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 15791522.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In our large observational cohort, use of tenofovir disoproxil fumarate (n=344) was associated with a greater decline in renal function than was use of alternative nucleoside analogues (n=314). Other associations included a lower CD4 cell count, decreased renal function at baseline, and diabetes. The declines were modest and did not lead to greater rates of discontinuation of therapy.
Medical subject headings
- Adenine
- Anti-HIV Agents
- HIV Infections
- Kidney Diseases
- Organophosphonates
- Reverse Transcriptase Inhibitors